Harvard licenses stem cell assays to Life Technologies

03/5/2013 | Genetic Engineering & Biotechnology News

Harvard University granted Life Technologies exclusive development rights for characterization assays to assess human pluripotent stem cells for use in discovery and research. The assays, developed by Harvard associate professor Alex Meissner, will be offered in Life's semiconductor sequencing and PCR-based systems.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care